$EW

AI 分析

生成于 May 11, 2026

AI Score
70/ 100
Hold$EW

Edwards Lifesciences

$EWNYSEHealthcareLarge-Cap

Edwards Lifesciences develops transcatheter heart valve replacement and hemodynamic monitoring products.

Market Cap
$42.0B
Revenue (TTM)
$6.1B
+8.0%
Net Income (TTM)
$1.5B
+12.0%
EPS (TTM)
$2.50
P/E Ratio
32.0
Dividend Yield
0.0%
52-Week Range
$55-$95
Beta
0.95
Dimension Scores
Fundamental
72
Technical
66
Sentiment
68
Risk / Reward
72
Momentum
66
FundTechSentRiskMome
Financial Health
Profitability
77strong
Growth
69moderate
Liquidity
80strong
Solvency
74strong
Efficiency
70strong

Valuation, technical analysis, investment thesis, risk assessment and more for $EW

Free · No credit card required

免责声明: AI 生成的分析仅供教育参考,不构成投资建议。请始终咨询合格的理财顾问。

探索更多

用 AI 分析任意股票

获取涵盖基本面、技术面、情绪面、风险评估和投资论点的结构化研究报告——约 60 秒完成。